The effect of gender and the neurotrophin, BDNF, upon methamphetamine- induced neurotoxicity of the nigrostriatal dopaminergic system in mice

Neuroscience Letters

Volumn 359, Issue 3, 2004, Pages 135-138

  Dluzen, Dean E ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Neurodegeneration; Neuroprotection; Parkinson's disease; Sex differences

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; METHAMPHETAMINE; NEUROTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; MALE; MOUSE; MUTANT; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MICE; MICE, TRANSGENIC; MUTATION; NEUROTOXICITY SYNDROMES; SEX FACTORS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTANTIA NIGRA;

EID: 1842504371     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.01.061     Document Type: Article

References (20)

1. Alonso-Vanegas M.A., Fawcett J.P., Causing C.G., Miller F.D., Sadikot A.F. Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse. J. Comp. Neurol. 413:1999;449-462.
2. Beck K.D. Functions of brain-derived neurotrophic factor, insulin-like growth factor and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons. Prog. Neurobiol. 44:1994;497-516.
3. Betarbet R., Sherer T.B., Greenamyre J.T. Animal models of Parkinson's disease. BioEssays. 24:2002;308-318.
4. Blochl A., Sirrenberg C. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75 LNTR receptors. J. Biol. Chem. 271:1996;21100-21107.
5. Conover J.C., Erickson J.T., Katz D.M., Bianchl L.M., Poueymirou W.T., McClain J., Pan L., Helgren M., Ip N.Y., Boland P., Friedman B., Wiegand S., Vejsada R., Kato A.C., DeChiara T.M., Yancopoulos G.D. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature. 375:1995;235-237.
6. Dluzen D.E., Anderson L.I., McDermott J.L., Kucera J., Walro J.M. Striatal dopamine output is compromised within +/- BDNF mice. Synapse. 43:2002;112-117.
7. Dluzen D.E., Gao X., Story G.M., Anderson L.I., Kucera J., Walro J.M. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp. Neurol. 170:2001;121-128.
8. Dluzen D.E., Story G.M., Xu K., Kucera J., Walro J.M. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp. Neurol. 160:1999;500-507.
9. Dluzen D.E., Tweed C., Anderson L.I., Laping N.J. Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system. Neuroendocrinology. 77:2003;232-238.
10. Ernfors P., Lee K.F., Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature. 368:1994;147-150.
11. Hall J.N., Broderick P.M. Community networks for response to abuse outbreaks of methamphetamine and its analogs. NIDA Res. Monogr. 115:1991;109-120.
12. Hoglinger G., Sautter U.J., Meyer M., Spenger C., Seiler R.W., Oertel W.H., Widmer H.R. Rat fetal mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function. Brain Res. 813:1998;313-322.
13. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
14. Joyce J.N., Renish L., Osredkar T., Walro J.M., Kucera J., Dluzen D.E. Methamphetamine induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Synapse. 2004;. (in press).
15. Knusel B., Winslow J.W., Rosenthal A., Burton L.E., Seid D.P., Nikolics K., Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. 88:1991;961-965.
16. Matsuki H., Shirayama Y., Hashimoto K., Tanaka A., Minabe Y. Effects of age and gender on the expression of brain-derived neurotrophic factor mRNA in rat retrosplenial cortex following administration of dizocilpine. Neuropsychopharmacology. 25:2001;258-266.
17. Miller D.B., Ali S.F., O'Callaghan J.P., Laws S.C. The impact of gender and estrogen on striatal dopamine neurotoxicity. Ann. N. Y. Acad. Sci. 844:1998;153-165.
18. Narita M., Aoki K., Takagi M., Yajima Y., Suzuki T. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience. 119:2003;767-775.
19. Wagner G.C., Tekirian T.L., Cheo C.T. Sexual differences in sensitivity to methamphetamine toxicity. J. Neural Transm. Gen Sect. 93:1993;67-70.
20. Yu L., Liao P.-C. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J. Neural Transm. 107:2000;419-427.